NetraMark Holdings Inc

Canadian Securities Exchange:AIAICanadaView on OTCQB

NetraMark Holdings Inc. is a Canada-based company, which is focused on the development of Generative Artificial Intelligence (Gen AI)/Machine Learning (ML) solutions targeted at the pharmaceutical industry. The Company’s product offering uses a novel topology-based algorithm that has the ability to parse patient data sets into subsets of people that are strongly related according to several variables simultaneously. This allows the Company to use a variety of ML methods, depending on the character and size of the data, to transform the data into powerfully intelligent data that activates traditional AI/ML methods. The result is that it can work with smaller datasets and accurately segment diseases into different types, as well as accurately classify patients for sensitivity to drugs and/or efficacy of treatment. The typical molecular data used is RNASeq, microarray, single nucleotide polymorphism (SNP) and methylation.

Contact Information

Headquarters

Suite 101 - 1655 Dupont StreetToronto, ON, Canada M6P 3T1

Phone

647-223-7165

Fax

---

Executives

Independent Chairman of the Board

Kevin Taylor

President, Chief Executive Officer, Director

George Achilleos

Chief Financial Officer

Swapan Kakumanu

President of NetraMark Corp

Josh Spiegel

Chief Scientific Officer, Director

Joseph Geraci